Tagasi

EVS-EN ISO 10993-12:2021

Meditsiiniseadmete bioloogiline hindamine. Osa 12: Proovi ettevalmistamine ja etalonained

Üldinfo
Kehtiv alates 01.07.2021
Alusdokumendid
ISO 10993-12:2021; EN ISO 10993-12:2021
Direktiivid või määrused
puuduvad
Standardi ajalugu
Staatus
Kuupäev
Tüüp
Nimetus
01.07.2021
Põhitekst
05.09.2012
Põhitekst
This document specifies requirements and gives guidance on the procedures in the preparation of samples and the selection of reference materials for medical device testing primarily in biological test systems primarily in accordance with one or more parts of the ISO 10993 series. Specifically, this document addresses the following: - test sample selection; - selection of representative portions from a medical device; - test sample preparation; - experimental controls; - selection of, and requirements for, reference materials; - preparation of extracts. This document is not applicable to live cells but can be relevant to the material or medical device components of combination products containing live cells. Extractions for chemical characterization are covered in ISO 10993-18. Clause 7, 8, 9, 10 [with the exception of 10.3.5 and 10.3.11 b)], and 11 can apply to extractions for chemical characterization. Information given in C.1 to C.4 can also be relevant.
*
*
*
PDF
15,86 € koos KM-ga
Paber
15,86 € koos KM-ga
Hind: 2,40 € koos KM-ga
Standardi monitooring
Teised on ostnud veel
Põhitekst

EVS-EN ISO 10993-18:2020

Meditsiiniseadmete bioloogiline hindamine. Osa 18: Meditsiiniseadme materjalide keemiline iseloomustamine riskihaldusprotsessis
Uusim versioon Kehtiv alates 15.06.2020
Põhitekst

EVS-EN ISO 10993-1:2020

Meditsiiniseadmete bioloogiline hindamine. Osa 1: Hindamine ja katsetamine riskihaldusprotsessis
Uusim versioon Kehtiv alates 31.12.2020
Põhitekst

EVS-EN ISO 20417:2021

Meditsiiniseadmed. Tootja esitatav teave
Uusim versioon Kehtiv alates 17.05.2021
Põhitekst

EVS-EN ISO 80369-7:2021

Small-bore connectors for liquids and gases in healthcare applications - Part 7: Connectors for intravascular or hypodermic applications (ISO 80369-7:2021)
Uusim versioon Kehtiv alates 01.06.2021